RESEARCH USE ONLY. Reference data for laboratory research. Not medical advice; not for human consumption.
← Directory

Protocol Single compound

Epitalon

Epithalon, AEDG

Synthetic tetrapeptide investigated for telomerase activity and circadian/pineal regulation.

Compare side by side →

Protocol card · research reference

Starting dose
5 mg
Studied range
5–10 mg
Frequency
Once daily
Route
Subcutaneous
Cycle
10–20 days, 1–2× per year

Reconstitution reference

Storage: Powder: 2–8 °C, or −20 °C for longer storage. After mixing with BAC water: 2–8 °C, use within about 4 weeks.

Epitalon

Once daily · units to draw on a U-100 syringe for a 5 mg dose.

VialBAC watermg/mLDrawDoses
10 mg1 mL1050 u2
10 mg2 mL5100 u2
10 mg3 mL3.33150 u2
50 mg1 mL5010 u10
50 mg2 mL2520 u10
50 mg3 mL16.6730 u10

Calculate your vial

Add reminder

Enter your own schedule. Saved only on this device — never sent anywhere.

Research use only — educational reference, not medical advice. This line is added to every reminder.

Works with iPhone Calendar, Google Calendar and Outlook.

Saved only in this browser. My reminders

Inputs
mg
mL
1 mg = 1,000 mcg
mg

Draw to

—units

= — mL on a U-100 syringe

Concentration
—
Per unit
—
Doses / vial
—
Syringe
01020304050607080901000.0u
U-100 · 100 units (1 mL)2 unit per line

Research dossier · published literature summary

01

Mechanism of action

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide based on epithalamin, a bovine pineal extract. Reported effects include melatonin-synthesis changes, enzyme activation including telomerase, and antioxidant activity; reviewers note the mechanism is not fully established.

02

Observed research endpoints

  • A 2025 review summarised about 25 years of in vitro, animal and in silico work describing geroprotective and neuroendocrine effects.
  • In human cell lines, epitalon extended telomere length dose-dependently in normal cells via hTERT and telomerase upregulation; in breast-cancer lines it acted through ALT activation.

03

Regulatory & safety context

  • Not approved by the FDA or EMA for any indication; research-grade material is not a medicine.
  • Most published work comes from a small number of research groups; physico-chemical and structural studies remain limited.
  • No large controlled human safety dataset is available.

04

Citations

  1. Araj SK, et al. Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025;26(6).2025-03Narrative reviewRead paper ↗
  2. Al-Dulaimi S, et al. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26(5):178.2025-09In vitro studyRead paper ↗

Keep exploring

Where researchers source it

Listings are provided for reference — always verify the latest third-party COA before purchasing.

Medvinci Research

See site

Featured supplier · third-party tested, COA published per batch

Supplier B

TBD

Placeholder — details coming soon

View productView COA

Supplier C

TBD

Placeholder — details coming soon

View productView COA